142 results
Page 3 of 8
8-K
EX-4.2
15hqeuc0par 3k4fiu
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.1
emasgt
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.2
8i5eicltl85
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.1
bmp2owngeetkcd9ahef8
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.3
1urdud6ki1c
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
c3es7l8i
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
k2okongsws66jer
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
4zaf37kmn2 1k
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
xlkll2f dz
7 Apr 22
Prospectus supplement
4:46pm
S-3
s0acp4dqgglotq ltlx
4 Feb 22
Shelf registration
4:36pm
8-K/A
EX-99.3
8f2meu0pqt
22 Dec 21
Audited Financial Statements
12:00am
8-K/A
EX-99.1
0bhon nom3t
22 Dec 21
Audited Financial Statements
12:00am
8-K/A
EX-99.2
asd b9ntyh
22 Dec 21
Audited Financial Statements
12:00am
DEF 14A
t4tb5ojl tbmnn5
28 Oct 21
Definitive proxy
3:07pm
8-K
EX-2.1
75dea
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm